MRNA

Moderna (MRNA) did not distribute dividends in the last year.

Currently, Moderna (MRNA) is priced at $ 23.56, with a P/E of -3.63%%, representing a deviation of 15%% from its historical average P/E. In the last year, the stock showed a variation of -55.79% in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%%. The total shareholder return was -55.79%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Investing in stocks of Moderna (MRNA) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

The yield of Moderna (MRNA) was -14.45% in the last month, -55.79% in the last year and -69.69% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%%.

If you wanted to buy 100 stocks of Moderna (MRNA) today, the total investment would be $ 2,356.00, based on the current price of $ 23.56.

If past performance were to repeat, the return on your investment would be:

• In 1 year: $ 1,041.59
• In 5 years: $ 714.10
• In 10 years: $ 2,356.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.